Healthcare >> Analyst Interviews >> July 13, 2009

Diagnostics Industry Progress Investment Highlights – Stephen D. Simpson – Northland Securities

Stephen D. Simpson, CFA, joined Northland Securities in December 2008 as a Senior Analyst covering medical technology companies. Mr. Simpson has extensive experience in the health care sector, having worked as a sell-side Equity Analyst at Piper Jaffray and more recently as a Consultant to the health care industry, focusing on the life sciences and metabolic/endocrine disease markets. He has a B.S.L.A. in Japanese from Georgetown University and holds a Series 7, Series 63, Series 86 and Series 87 license. Profile
TWST: Can you start by giving me an overview of your segment of the life

sciences and medical labs industry that you follow? If you want to mention some

of the companies you follow as well, that